Latest Financial Valuations News

Elanor Commercial Property Fund’s Independent Board Committee unanimously recommends rejecting Lederer’s unsolicited $0.70 per security takeover bid, supported by an Independent Expert’s report deeming the offer neither fair nor reasonable.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.